1. Home
  2. PSTX vs NRC Comparison

PSTX vs NRC Comparison

Compare PSTX & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTX
  • NRC
  • Stock Information
  • Founded
  • PSTX 2014
  • NRC 1981
  • Country
  • PSTX United States
  • NRC United States
  • Employees
  • PSTX N/A
  • NRC N/A
  • Industry
  • PSTX Biotechnology: Biological Products (No Diagnostic Substances)
  • NRC Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • PSTX Health Care
  • NRC Health Care
  • Exchange
  • PSTX Nasdaq
  • NRC Nasdaq
  • Market Cap
  • PSTX 360.4M
  • NRC 426.3M
  • IPO Year
  • PSTX 2020
  • NRC N/A
  • Fundamental
  • Price
  • PSTX $2.71
  • NRC $19.46
  • Analyst Decision
  • PSTX Strong Buy
  • NRC
  • Analyst Count
  • PSTX 2
  • NRC 0
  • Target Price
  • PSTX $15.00
  • NRC N/A
  • AVG Volume (30 Days)
  • PSTX 557.2K
  • NRC 83.2K
  • Earning Date
  • PSTX 11-07-2024
  • NRC 10-25-2024
  • Dividend Yield
  • PSTX N/A
  • NRC 2.51%
  • EPS Growth
  • PSTX N/A
  • NRC N/A
  • EPS
  • PSTX N/A
  • NRC 1.12
  • Revenue
  • PSTX $150,858,000.00
  • NRC $144,155,000.00
  • Revenue This Year
  • PSTX $64.38
  • NRC N/A
  • Revenue Next Year
  • PSTX N/A
  • NRC N/A
  • P/E Ratio
  • PSTX N/A
  • NRC $16.70
  • Revenue Growth
  • PSTX 203.18
  • NRC N/A
  • 52 Week Low
  • PSTX $1.87
  • NRC $17.62
  • 52 Week High
  • PSTX $4.27
  • NRC $42.19
  • Technical
  • Relative Strength Index (RSI)
  • PSTX 46.81
  • NRC 50.39
  • Support Level
  • PSTX $2.63
  • NRC $18.33
  • Resistance Level
  • PSTX $2.82
  • NRC $21.64
  • Average True Range (ATR)
  • PSTX 0.33
  • NRC 0.79
  • MACD
  • PSTX -0.03
  • NRC 0.01
  • Stochastic Oscillator
  • PSTX 19.86
  • NRC 38.24

About PSTX Poseida Therapeutics Inc.

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

About NRC National Research Corporation (Delaware)

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.

Share on Social Networks: